Comprehensive Management of Sickle Cell Disorders

Sickle cell disease is a lifelong, multisystem disorder that affects far more than just the blood. Because of its wide-ranging complications, it requires thoughtful, individualized care delivered by a coordinated multidisciplinary team. Early diagnosis, along with preventive and supportive measures—such as vaccination, infection prophylaxis, hydroxyurea therapy, and appropriate transfusion strategies—can substantially reduce both complications and early mortality. These foundational treatments have transformed outcomes over the past few decades. For some patients, potentially curative options like hematopoietic stem cell transplantation and newer gene-based therapies offer real hope, although issues related to cost, access, and long-term safety remain important considerations. At the same time, prompt and effective management of acute complications—such as vaso-occlusive crises, acute chest syndrome, and transfusion-related problems—is essential to preserving organ function and improving survival. Special situations, including pregnancy and stroke prevention, further highlight the need for structured long-term follow-up and careful planning. Continued research, strong public health initiatives, and equitable access to emerging therapies will be critical to improving the lives of individuals living with sickle cell disease worldwide.